Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
10.1016/j.annonc.2023.07.011
Saved in:
Main Authors: | González-Martín, A, Harter, P, Leary, A, Lorusso, D, Miller, RE, Pothuri, B, Ray-Coquard, I, Tan, DSP, Bellet, E, Oaknin, A, Ledermann, JA |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
Elsevier BV
2023
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/244720 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Immune checkpoint inhibitors in ovarian cancer: where do we stand?
by: Leary, A, et al.
Published: (2021) -
Decreased plasma granulysin and increased interferon-gamma concentrations in patients with newly diagnosed and relapsed tuberculosis
by: Nada Pitabut, et al.
Published: (2018) -
Epithelial ovarian cancer
by: Ng, J.S., et al.
Published: (2016) -
Tracheobronchial involvement in relapsing polychondritis diagnosed on endobronchial ultrasound
by: Dararat Eksombatchai, et al.
Published: (2018) -
Treatment outcome of thalidomide based regimens in newly diagnosed and relapsed/refractory non-transplant multiple myeloma patients: A single center experience from Thailand
by: Pimjai Niparuck, et al.
Published: (2018)